Compare VNDA & ANSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VNDA | ANSC |
|---|---|---|
| Founded | 2002 | 2021 |
| Country | United States | United States |
| Employees | N/A | 2 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.0M | 469.1M |
| IPO Year | 2005 | N/A |
| Metric | VNDA | ANSC |
|---|---|---|
| Price | $7.26 | $11.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.90 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 1.5K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $216,105,000.00 | N/A |
| Revenue This Year | $21.35 | N/A |
| Revenue Next Year | $37.40 | N/A |
| P/E Ratio | ★ N/A | $55.07 |
| Revenue Growth | ★ 8.72 | N/A |
| 52 Week Low | $3.81 | $10.67 |
| 52 Week High | $9.91 | $11.30 |
| Indicator | VNDA | ANSC |
|---|---|---|
| Relative Strength Index (RSI) | 47.83 | 69.63 |
| Support Level | $7.12 | $11.13 |
| Resistance Level | $7.79 | N/A |
| Average True Range (ATR) | 0.32 | 0.05 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 61.07 | 100.00 |
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Agriculture & Natural Solutions Acquisition Corp is a blank check company.